The distinction between radiation necrosis and recurrent highgrade glioma remains a challenge despite advanced imaging techniques such as perfusion and diffusionweighted mr imaging 15, mr spectroscopy, and positron emission tomography 79. Axial sections of the brain showing a heterogeneously enhancing lesion a in the right temporoparietal region in the operated bed with no significant perfusion d, no diffusion restrictione, no fdg uptakec and no significant choline on mr spectroscopy f favoring radiation necrosis. Recurrent radiation necrosis in the brain following. Radiation necrosis in the brain commonly occurs in three distinct clinical scenarios, namely, radiation therapy for head and neck. Differentiation of radiation necrosis from glioblastoma. A challenge faced by clinicians is in the diagnosis and management of a suspicious gadoliniumenhancing lesion found on imaging. Vellayappan b, tan cl, yong c, khor lk, koh wy, yeo tt, detsky j, lo s and sahgal a 2018 diagnosis and management of radiation necrosis in patients with brain metastases. Mri, cerebral blood flow, electrophysiological, and histological studies. Radiation change generally exhibits low naa, creatine, and choline on spectroscopy. Proton magnetic resonance spectroscopy is a noninvasive technique that. Distinguishing between radiation necrosis and tumoral recurrence represents a difficult diagnostic challenge. A critical question for the clinical management of patients with brain tumors is whether multivoxel mrs is able to add new information to the highquality anatomical data provided. Radiation therapy is an important modality used in the treatment of patients with brain metastatic disease and malignant gliomas. The current standard of care for gbm is surgical excision followed by radiation therapy rt with concurrent and adjuvant temozolomidebased chemotherapy tmz by six additional cycles.
Posttreatment surveillance often involves serial magnetic resonance imaging. A complete understanding of the pathophysiology of rn and chemotherapyinduced injury to the central nervous system is useful in understanding. Patients present from several months to 10 years after cranial radiation. This may occur after a median interval of 7 to 11 months, but sometimes after more than 5 years. Pseudoprogression of brain tumors thust 2018 journal. Purpose this metaanalysis examined roles of several metabolites in differentiating recurrent tumor from necrosis in patients with brain tumors using mr perfusion and spectroscopy. These experiments showed that the radiation tolerance of the brain was intricately linked to dose, volume of treatment and was a function of time elapsed since radiation. It can increase lesion conspituity by suppressing normal tissues. Accuracy of magnetic resonance spectroscopy in distinction.
Differentiation between brain tumor recurrence and. Detecting a new area of contrast enhancement in or in the vicinity of a previously treated brain tumor always causes concern for both the patient and the physician. It can identify abnormalities not seen on conventional mri, for example, invasion of a glioblastoma multiforme gbm into adjacent brain where there is no enhancement or t2 abnormality on mri. Grossman and yousem said if you need this to help you, go back to page 1. Brain metastases are estimated to account for approximately 2550% of intracranial tumours in hospitalised patients. Accuracy of magnetic resonance spectroscopy in distinction between radiation necrosis and recurrence of brain tumors. Radiation necrosis in the brain commonly occurs in three distinct clinical scenarios, namely, radiation therapy for head and neck malignancy or intracranial extraaxial tumor, stereotactic radiation therapy including radiosurgery for brain metastasis, and radiation therapy for primary brain tumors. Twodimensional csi mr spectroscopy can differentiate tumor from radiation injury. Radiation necrosis may explain up to half of the lesions that. Fundamentals of mr spectroscopy center for functional. Magnetic resonance spectroscopy mrs in the evaluation of brain tumors either primary. Mr spectroscopy in posttreatment follow up of brain tumors. The question that immediately arises is whether this new lesion is recurrent tumor or a treatment effect. In these lesions, the chonaa and chocr ratios may be the best numeric discriminators.
Review article mr spectroscopy in radiation injury p. Brain tumor metabolism was studied with hydrogen1 magnetic resonance spectroscopy and positron emission tomography with fluorine18 fluorodeoxyglucose in 50 patients. Clinical application of mr spectroscopy in identifying. The management of brain necrosis as a result of srs. A patient with glioblastoma, post radiotherapy developed magnatic resonance imaging mri changes consistent with either radiation induced tumor necrosis or tumor recurrence. Diagnosis and management of radiation necrosis in patients.
If radiation necrosis is present, the spectrum may reveal elevated lipids and lactate. Magnetic resonance spectroscopy mrs medical clinical policy. Magnetic resonance spectroscopy mrs complements magnetic resonance imaging mri as a noninvasive means for the characterization of tissue. Diagnosis and treatment of progressive spaceoccupying radiation necrosis following stereotactic radiosurgery for brain metastasis. Teaching case recurrent radiation necrosis in the brain following stereotactic radiosurgery gregory m. Differentiating tumor recurrence from treatment necrosis. Latedelayed radiation effects, on the other hand, may occur 3 months to years after radiation treatment, are often progressive, and may require additional intervention to mitigate their effects.
About frontiers institutional membership books news frontiers social. Mr spectroscopy can differentiate recurrentresidual tumor from. Mr spectroscopy is conducted on the same machine as conventional mri. It can distinguish between two or more abnormalities that appear the same on mri, for example, recurrent gbm versus radiation necrosis. Brain metastases are estimated to account for approximately 2550% of intracranial tumors in hospitalized patients. R i grossman, c m hechtleavitt, s m evans, r e lenkinski, g a holland, t j van winkle. Magnetic resonance spectroscopy, positron emission. Differentiation between brain tumor recurrence and radiation injury using mr spectroscopy.
Radiation necrosis an overview sciencedirect topics. Among the noninvasive methods that are available for diagnosing intracranial tumors, which include spect, pet, and diffusion and perfusionweighted mri 36, it is mainly proton mr spectroscopic imaging mr spectroscopy that has been used in attempts to differentiate tumor from radiation necrosis. Mrs in differentiating glioma recurrence from radiation necrosis. Clinical application of mr spectroscopy in identifying biochemical. Diagnosis and treatment of progressive spaceoccupying. The incidence of necrosis after radiotherapy for brain tumors is reported to be between 3% and 24%.
Mr spectroscopy, and positron emission tomography can be useful in differentiating between recurrent tumor and radiation necrosis. Radiation necrosis is a known complication following radiation therapy for extracranial and intracranial malignancies and should be considered in patients after radiotherapy for npc presenting with neurologic complaints cheng et al. Mr imaging characteristics of highgrade tumor classically include intravenous contrast enhancement, mass effect, and associated vasogenic. Exacerbation of cerebral radiation necrosis by bevacizumab. Perfusion mri was suggestive of radiation necrosis, but magnetic resonance spectroscopy and 99m tctetrofosmin single photon emission computed tomography was indicative of. Mr spectroscopy in radiation injury american journal of. Stereotactic radiosurgery srs is now a standard of care for recurrent malignant, metastatic and nonmalignant brain tumors. Cerebral radiation necrosis typically presents 3 to 12 months after radiotherapy but can occur years after treatment. A metaanalysis of studies using mr spectroscopy for evaluating. Differentiation between brain tumor recurrence and radiation. Multiparametric mri for differentiation of radiation necrosis from recurrent tumor. Magnetic resonance spectroscopy mrs provides useful information regarding. The textbook abeloffs clinical oncology 2008 states that new imaging.
Multivoxel magnetic resonance spectroscopy of brain. Naa is also helpful for the differentiation of primary brain tumors from metastasis and. Radiation necrosis, pseudoprogression, pseudoresponse, and. Radiation necrosis occurs in patients treated with high focal doses of radiation. In addition, antiangiogenic therapy with an antivascular endothelial growth factor vegf. Mrs cannot always distinguish primary and secondary tumors of the brain from one another. Cerebral radiation necrosis refers to necrotic degradation of brain tissue following intracranial or regional radiation either delivered for the treatment of intracranial pathology e. Early experiments were done on rats and dogs with singlefraction brain radiation 1025 gy. Symptomatic radiation necrosis correlated with 12 gy volume. Diffusion weighted imaging in radiation necrosis journal. Magnetic resonance spectroscopy diagnosis of neurological diseases. Diffusion weighted mri and magnetic resonance spectroscopy to differentiate radiation necrosis and recurrent disease in gliomas. Reversal of cerebral radiation necrosis with bevacizumab. Cerebral radiation necrosis radiology reference article.
Furthermore, because many pathologies appear similar in diagnostic imaging such as radiationinduced necrosis and recurring tumor following radiotherapy. Radiation oncologytoxicitybrain wikibooks, open books. Frontiers diagnosis and management of radiation necrosis. Risk of asymptomatic radiation necrosis did not relate to 12 gy volume. Diagnosis of cerebral radiation necrosis was based on the clinical presentations and radiologic imaging findings, including findings from magnetic resonance imaging mri, magnetic resonance spectroscopy mrs, perfusion mri, and 18 f2fluroddeoxyglucosepositron emission tomography fdgpet. Glioblastoma gbm is the most common primary malignant type of brain neoplasm in adults and carries a dismal prognosis. Role of magnetic resonance spectroscopy in differentiation between recurrence of glioma and post radiation injury. Retrospective, 129 pts with 198 nonavm tumors followed with mri every 36 months. It generally occurs 312 months after radiotherapy but can occur up to several years and even decades later 2, 6. Twodimensional csi mr spectroscopy can differentiate tumor from radiation injury in patients with recurrent contrastenhancing intracranial lesions. Evaluating magnetic resonance spectroscopy as a tool. All the patients were evaluated by standard brain mri protocol at our institution using a 1. Fat saturation is an alternative technique to improve image information in t1 wi post contrast mri of brain tumor. Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery.
Magnetic resonance spectroscopy mrs is becoming more widely available for clinical applications and is able to provide information about the metabolic properties of regions of normal and abnormal tissue morphology. While mri uses the signal from hydrogen protons to form anatomic images, proton mrs uses this information to determine the concentration of brain metabolites such as nacetyl aspartate naa, choline. Differentiating radiationinduced necrosis from recurrent. Anbarloui mr, ghodsi sm, khoshnevisan a, khadivi m, abdollahzadeh s, aoude a, et al. Moreover, in patients who are planned to undergo brain irradiation after definitive.
There are several different metabolites, or products of metabolism, that can be measured to differentiate between tumor types. Radiographic determination of necrosis and then the implementation of treatment are important to alleviate new neurological symptoms. Magnetic resonance spectroscopy mrs and spectroscopic imaging mrsi have been. Role of magnetic resonance spectroscopy in differentiation. The technique of magnetic resonance spectroscopy usually shortened to mr spectroscopy or mrs allows tissue to be interrogated for the presence and concentration of various metabolites. Protonmr spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors. This is perhaps a little harsh, however, it is fair to say that mrs.
Highgrade brain tumors, being metabolically active, can demonstrate. Primary brain tumors frequently return after radiation therapy rt. Radiation necrosis rn in patients with malignant gliomas is a severe local tissue reaction to radiotherapy. Significantly reduced cho and cr levels suggest radiation necrosis. Creatine is one of the compounds examined in mr spectroscopy. Proton mr spectroscopy is a useful tool in diagnosing metabolic brain disorders when used as an adjunct to conventional mri. Fortunately only a small number of tumors treated will result in asymptomatic or symptomatic necrosis. Radiation was applied as whole brain radiotherapy wbrt using the. Due to great variation in imaging appearances, these metastases present a common diagnostic challenge which can importantly affect the management approach for. Mr spectroscopy in posttreatment follow up of brain.
1243 280 835 1263 809 863 108 601 303 788 993 1518 340 1315 1024 188 1405 969 1414 554 589 1373 891 1256 1368 876 1471 844 244 207 322 233 698 1264 826